QUESTION 1: WHAT NEUROIMAGING TECHNOLOGY IS USED TO ASSESS THE SIZE AND VOLUME OF CERTAIN BRAIN AREAS IN PEOPLE WITH AUTISM?
QUESTION 2: WHAT MEASURE OF BRAIN ACTIVITY ALLOWS RESEARCHERS TO MAP BRAIN AREAS ASSOCIATED WITH SPECIFIC FUNCTIONS IN PEOPLE WITH AUTISM?
QUESTION 3: WHAT NEUROIMAGING TECHNOLOGY ASSESSES BRAIN METABOLISM AND SHOWS AREAS OF THE BRAIN WITH ABNORMAL ACTIVITY?
QUESTION 4: WHAT IS REVEALED BY DIFFUSION TENSOR IMAGING (DTI) IN NEUROIMAGING IN AUTISM?
5TH QUESTION: WHAT HAVE MRI STUDIES IN PEOPLE WITH AUTISM SHOWN IN RELATION TO THE SIZE AND VOLUME OF CERTAIN BRAIN AREAS?
QUESTION 6: WHAT DOES HYPERCONNECTIVITY IMPLY IN THE CONTEXT OF NEUROIMAGING IN AUTISM?
QUESTION 7: WHAT ADVANTAGE DOES NEUROIMAGING OFFER IN THE DIAGNOSIS OF AUTISM?
QUESTION 8: WHAT SHOULD FUTURE RESEARCH IN THE FIELD OF NEUROIMAGING AND AUTISM FOCUS ON?
Please, log in to have your progress recorded. Without logging in, you will be able to take the test but your progress in the course will not be increased